XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Stock - Additional Information (Detail) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended 3 Months Ended 1 Months Ended 3 Months Ended 3 Months Ended
Aug. 09, 2013
May 17, 2013
Mar. 31, 2014
Dec. 31, 2013
Mar. 31, 2013
Jun. 29, 2012
May 17, 2013
Common Stock [Member]
Mar. 31, 2014
Common Stock [Member]
Mar. 31, 2014
Employee Stock Purchase Plan [Member]
Mar. 31, 2014
Warrant 1 [Member]
Mar. 31, 2014
Warrant 2 [Member]
Mar. 31, 2014
Warrant 3 [Member]
Jun. 29, 2012
Warrant 4 [Member]
Mar. 31, 2014
Series A-1 Preferred Stock [Member]
May 17, 2013
Series A-1 Preferred Stock [Member]
Jun. 29, 2012
Series A-1 Preferred Stock [Member]
Jun. 29, 2012
Series A-1 Preferred Stock [Member]
Pyxis Innovations Inc [Member]
Jun. 29, 2012
Series B Preferred Stock [Member]
Mar. 31, 2014
Series B Preferred Stock [Member]
May 17, 2013
Series B Preferred Stock [Member]
Mar. 31, 2014
Placement Agent Warrants [Member]
Aug. 09, 2013
Placement Agent Warrants [Member]
Jun. 30, 2013
Placement Agent Warrants [Member]
May 17, 2013
Placement Agent Warrants [Member]
Stockholders Equity [Line Items]                                                
Convertible preferred stock, par value     $ 0.001                                          
Convertible preferred stock, shares authorized     6,000,000                                          
Convertible preferred stock, shares issued                               5,000,000 5,000,000 500,000            
Common stock, shares authorized   150,000,000 300,000,000 300,000,000 150,000,000                                      
Common stock, par value     $ 0.001 $ 0.001                                        
Common stock, outstanding or reserved for issuance     198,379,556                                          
Common stock, shares outstanding     122,481,674 122,448,707                                        
Shares reserved for conversion of Preferred to common stock                           28,160,200                    
Shares reserved for potential exercise     6,146,700                                          
Shares reserved for exercise of outstanding warrants                   1,750,000 437,158 35,081,967 437,158                      
Warrants exercise price per share   0.2745       0.2745       1.30 0.2745 0.2745 0.2745               0.2745      
Expiration date of warrants                   Mar. 05, 2015 Jun. 29, 2017                          
Proceeds from private placement of preferred stock   $ 12,000,000         $ 12,000,000                     $ 3,000,000            
Convertible preferred stock current conversion price     $ 0.3196                                          
Net Proceeds from issuance of Series B Convertible preferred Stock                                   2,700,000            
Convertible preferred stock, liquidation preference   24,000,000                         18,000,000         6,000,000        
Convertible preferred stock, effective purchase price                           $ 1.80         $ 6.00          
Shares Reserved For Exercise Of Rights                 605,920                              
Class Of Warrant Or Right Exercisable Number Of Warrants Or Rights   32,786,885                   20,655,737                        
Warrant Exercisable Expiration Date                       May 17, 2020                        
Shares Reserved For Issuance Of Common Stock And Warrants     31,876,137                                          
Additional Pro Rata InvestmentIn Common Stock And Warrants     5,000,000         5,000,000                                
Fair Value Adjustment of Warrants     104,907                                          
Conversion of Stock, Shares Converted     39,089,161                               10,928,961          
Convertible Preferred Stock, Shares Issued upon Conversion               39,089,161                                
Stock Issued During Period Shares New Issues             43,715,847                                  
Share Price             $ 0.2745                                  
Percentage Of Warrants Exercisable     63.00%                                          
Percentage Of Warrants Exercisable After Shareholder Approval     37.00%                                          
NoncashInterest Expense                                         286,579      
Increase In Common Stock Shares Authorized 300,000,000 300,000,000                                            
Increase In Interest Expense 11,000                                              
Allocated Share-based Compensation Expense                                         780,000      
Warrants To Purchase Of Common Stock                                         2,295,082      
Warrants Fair Value Disclosure                                           $ 5,369,676 $ 5,358,708 $ 5,072,129